Projects funded by the NCN
Actin cytoskeleton disorders as a pro-survival signaling activator and a therapeutic biomarker in Diffuse Large B-cell Lymphoma (DLBCL).
2023/50/E/NZ5/00384
Keywords:
Diffuse large B cell lymphoma actin cytoskeleton B cell receptor
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Hematologii i Transfuzjologii
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: SONATA BIS 13 - announced on 2023-06-19
Amount awarded: 4 070 990 PLN
Project start date (Y-m-d): 2024-06-20
Project end date (Y-m-d): 2029-06-19
Project duration:: 60 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.